https://www.selleckchem.com/products/t-5224.html
022). The 90-day mortality (1.4% MITP vs 7.1% OTP, P = 0.209) and median hospital stay (17 [IQR 11-24] MITP vs 12 [10-23] days OTP, P = 0.876) did not differ significantly. Among 81 patients with PDAC, overall survival was 3.7 (IQR 1.7-N/A) vs 0.9 (IQR 0.5-N/A) years, for MITP vs OTP, which was non-significant after stratification by T-stage. This international propensity score matched study showed that MITP may be a valuable alternative to OTP in selected patients, given the associated lower rate of major morbidity. This international p